About us Contacts Drug interactions: 390 212
Drug search by name

Bortezomib Intravenous and Flintstones Toddler

Determining the interaction of Bortezomib Intravenous and Flintstones Toddler and the possibility of their joint administration.

Check result:
Bortezomib Intravenous <> Flintstones Toddler
Relevance: 20.08.2022 Reviewer: Shkutko P.M., M.D., in

In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.

Consumer:

Talk to your doctor before using bortezomib together with multivitamin with iron. Supplements that contain ascorbic acid, or vitamin C, may reduce the effectiveness of bortezomib in treating your cancer. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.

Professional:

GENERALLY AVOID: Preliminary data suggest that ascorbic acid may diminish the antitumor effects of bortezomib when taken simultaneously. In vitro, ascorbic acid has been shown to inhibit several biologic activities of bortezomib, including induction of apoptosis and G2-M cell cycle arrest and inhibition of proteasome activity, presumably by forming a complex with bortezomib that is both inactive and has poor membrane permeability into cells. A group of investigators showed that plasma from healthy volunteers taking 1 gram of vitamin C per day reduced bortezomib-induced multiple myeloma cell death in vitro. Using a mouse model of human multiple myeloma, they also found that oral vitamin C (40 mg/kg/day) blocked the inhibition of tumor cell growth induced by bortezomib (0.1 mg/kg twice a week for 4 weeks) in immunocompromised mice. The interaction has also been observed in an endometrial carcinoma cell line. In contrast, no effect of ascorbic acid (at plasma concentrations commensurate with human supplemental intake) on bortezomib activity was found in immunocompromised mice bearing CWR22 human prostate xenograft tumors. In light of the fact that vitamin C may protect normal cells from bortezomib toxicity, more studies are needed to further clarify the clinical significance of these findings.

MANAGEMENT: Until more data are available, it may be advisable to avoid taking supplements containing ascorbic acid during bortezomib therapy, or at least on bortezomib treatment days.

References
  • Catley L, Anderson KC "Velcade and vitamin C: too much of a good thing?" Clin Cancer Res 12 (2006): 3-4
  • Bannerman B, Xi L, Jones M, et al "Preclinical evaluation of the antitumor activity of bortezomib in combination with vitamin C or with epigallocatechin gallate, a component of green tea." Cancer Chemother Pharmacol 68 (2011): 1145-54
  • Zou W, Yue P, Lin N, et al. "Vitamin C inactivates the proteasome inhibitor PS-341 in human cancer cells." Clin Cancer Res 12 (2006): 273-80
Bortezomib Intravenous

Generic Name: bortezomib

Brand name: Velcade

Synonyms: Bortezomib (Intravenous)

Flintstones Toddler

Generic Name: multivitamin with iron

Brand name: Fero-Folic 500, Theragran Hematinic, Ultra Enerforce

Synonyms: Multivitamin with iron, Polysaccharide-Iron Complex, Vitamin B12, and Folic Acid

In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.

Interaction with food and lifestyle